loadpatents
name:-0.029303073883057
name:-0.020147085189819
name:-0.0025460720062256
Tsypin; Maxim Patent Filings

Tsypin; Maxim

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tsypin; Maxim.The latest application filed is for "predictive test for patient benefit from antibody drug blocking ligand activation of the t-cell programmed cell death 1 (pd-1) checkpoint protein and classifier development methods".

Company Profile
2.24.25
  • Tsypin; Maxim - Steamboat Springs CO
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Predictive Test For Patient Benefit From Antibody Drug Blocking Ligand Activation Of The T-cell Programmed Cell Death 1 (pd-1) Checkpoint Protein And Classifier Development Methods
App 20210098131 - Roder; Joanna ;   et al.
2021-04-01
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Grant 10,950,348 - Roder , et al. March 16, 2
2021-03-16
Predictive Test for Patient Benefit from Antibody Drug Blocking Ligand Activation of the T-Cell Programmed Cell Death 1 (PD-1) Checkpoint Protein and Classifier Development Methods
App 20180277249 - Roder; Joanna ;   et al.
2018-09-27
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
Grant 10,007,766 - Roder , et al. June 26, 2
2018-06-26
Method and system for determining whether a drug will be effective on a patient with a disease
Grant 9,824,182 - Roder , et al. November 21, 2
2017-11-21
Deep MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Grant 9,606,101 - Roder , et al. March 28, 2
2017-03-28
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
App 20170039345 - Roder; Joanna ;   et al.
2017-02-09
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
Grant 9,279,798 - Roder , et al. March 8, 2
2016-03-08
Deep MALDI TOF Mass Spectrometry of Complex Biological Samples, e.g., Serum, and Uses Thereof
App 20160018410 - Roder; Heinrich ;   et al.
2016-01-21
Method and system for determining whether a drug will be effective on a patient with a disease
Grant 9,152,758 - Roder , et al. October 6, 2
2015-10-06
Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samples
App 20140284468 - Grigorieva; Julia ;   et al.
2014-09-25
Deep-MALDI TOF mass spectrometry of complex biological samples, e.g., serum, and uses thereof
App 20130320203 - Roder; Heinrich ;   et al.
2013-12-05
Monitoring treatment of head and neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Grant 8,586,380 - Roder , et al. November 19, 2
2013-11-19
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Grant 8,586,379 - Roder , et al. November 19, 2
2013-11-19
Method and system for validation of mass spectrometer machine performance
Grant 8,467,988 - Roder , et al. June 18, 2
2013-06-18
Method and system for determining whether a drug will be effective on a patient with a disease
App 20120191370 - Roder; Heinrich ;   et al.
2012-07-26
Method and system for determining whether a drug will be effective on a patient with a disease
App 20120089341 - Roder; Heinrich ;   et al.
2012-04-12
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
App 20120074310 - Roder; Heinrich ;   et al.
2012-03-29
Monitoring treatment of Head and Neck cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
App 20120074311 - Roder; Heinrich ;   et al.
2012-03-29
Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples
Grant 8,119,417 - Roder , et al. February 21, 2
2012-02-21
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Grant 8,119,418 - Roder , et al. February 21, 2
2012-02-21
Method and system for determining whether a drug will be effective on a patient with a disease
Grant 8,097,469 - Roder , et al. January 17, 2
2012-01-17
Method to automatically identify peaks and monoisotopic peaks in mass spectral data for biomolecular applications
App 20110282588 - Tsypin; Maxim
2011-11-17
Method for reliable classification of samples in clinical diagnostics using an improved method of classification
Grant 8,024,282 - Tsypin , et al. September 20, 2
2011-09-20
Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samples
App 20110208433 - Grigorieva; Julia ;   et al.
2011-08-25
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
App 20110121167 - Roder; Heinrich ;   et al.
2011-05-26
Monitoring treatment of colorectal cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
App 20110121169 - Roder; Heinrich ;   et al.
2011-05-26
Monitoring treatment of head and neck cancer patients with drugs EGFR pathway using mass spectrometry of patient samples
App 20110121168 - Roder; Heinrich ;   et al.
2011-05-26
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
Grant 7,906,342 - Roder , et al. March 15, 2
2011-03-15
Method and system for determining whether a drug will be effective on a patient with a disease
Grant 7,879,620 - Roder , et al. February 1, 2
2011-02-01
Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
Grant 7,867,775 - Roder , et al. January 11, 2
2011-01-11
Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway
Grant 7,858,390 - Roder , et al. December 28, 2
2010-12-28
Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway
Grant 7,858,389 - Roder , et al. December 28, 2
2010-12-28
Method and system for determining whether a drug will be effective on a patient with a disease
App 20100305868 - Roder; Heinrich ;   et al.
2010-12-02
Method and system for determining whether a drug will be effective on a patient with a disease
App 20100204061 - Roder; Heinrich ;   et al.
2010-08-12
Method and system for determining whether a drug will be effective on a patient with a disease
App 20100174492 - Roder; Heinrich ;   et al.
2010-07-08
Method and system for determining whether a drug will be effective on a patient with a disease
Grant 7,736,905 - Roder , et al. June 15, 2
2010-06-15
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
App 20100055100 - Roder; Heinrich ;   et al.
2010-03-04
Selection of non-small-cell lung cancer patients for treatment with monoclonal antibody drugs targeting EGFR pathway
App 20090170215 - Roder; Heinrich ;   et al.
2009-07-02
Selection of colorectal cancer patients for treatment with drugs targeting EGFR pathway
App 20090170216 - Roder; Heinrich ;   et al.
2009-07-02
Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
App 20090171872 - Roder; Heinrich ;   et al.
2009-07-02
Method for reliable classification of samples in clinical diagnostics using an improved method of classification
App 20080306898 - Tsypin; Maxim ;   et al.
2008-12-11
Method and system for determining whether a drug will be effective on a patient with a disease
App 20070231921 - Roder; Heinrich ;   et al.
2007-10-04
Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications
App 20050267689 - Tsypin, Maxim
2005-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed